STATEMENT OF STOCKHOLDERS' EQUITY (USD $)	Total	Common Stock	Additional Paid-in Capital	Deficit Accumulated During Development Stage
Balances at Oct. 23, 2013
Increase (Decrease) in Stockholders' Equity
Sale of common stock to Sponsor on November 20, 2013 at approximately $.004 per share	$ 25,000	$ 604	$ 24,396
Sale of common stock to Sponsor on November 20, 2013 at approximately $.004 per share (in shares)		6,037,500
Balances at Dec. 31, 2013	25,000	604	24,396
Balances (in shares) at Dec. 31, 2013		6,037,500
Increase (Decrease) in Stockholders' Equity
Sale of 21,000,000 units on February 19, 2014	210,000,000	2,100	209,997,900
Sale of 21,000,000 units on February 19, 2014 (in shares)		21,000,000
Sale of 5,950,000 warrants to Sponsor on February 19, 2014	5,950,000		5,950,000
Reclassification of shares subject to possible redemption, at redemption value, on February 19, 2014	(198,816,420)	(1,988)	(198,814,432)
Reclassification of shares subject to possible redemption, at redemption value, on February 19, 2014 (in shares)		(19,881,642)
Sale of 1,050,000 units on March 13, 2014, pursuant to the underwriters' partial exercise of their over-allotment option	10,500,000	105	10,499,895
Sale of 1,050,000 units on March 13, 2014, pursuant to the underwriters' partial exercise of their over-allotment option (in shares)		1,050,000
Sale of 210,000 warrants to Sponsor on March 13, 2014, pursuant to the underwriters' partial exercise of their over-allotment option	210,000		210,000
Forfeiture of sponsor and independent directors shares on March 13, 2014, due to the underwriters' partial exercise of their over-allotment option		(53)	53
Forfeiture of sponsor and independent directors shares on March 13, 2014, due to the underwriters' partial exercise of their over-allotment option (in shares)		(525,000)
Reclassification of shares subject to possible redemption, at redemption value, on March 13, 2014	(10,126,953)	(101)	(10,126,852)
Reclassification of shares subject to possible redemption, at redemption value, on March 13, 2014 (in shares)		(1,012,695)
Underwriters' discount and offering expenses	(12,741,617)		(12,741,617)
Change in proceeds subject to possible redemption	232,816	2	232,814
Change in proceeds subject to possible redemption (in shares)		23,282
Net income/(loss) attributable to common stockholders	(232,816)			(232,816)
Balances at Jun. 30, 2014	$ 5,000,010	$ 669	$ 5,232,157	$ (232,816)
Balances (in shares) at Jun. 30, 2014		6,691,445